AnBogen Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- AnBogen Therapeutics's estimated annual revenue is currently $3.4M per year.
- AnBogen Therapeutics's estimated revenue per employee is $155,000
- AnBogen Therapeutics's total funding is $20M.
Employee Data
- AnBogen Therapeutics has 22 Employees.
- AnBogen Therapeutics grew their employee count by 22% last year.
AnBogen Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP, Business Development | Reveal Email/Phone |
2 | VP, Finance and Accounting | Reveal Email/Phone |
3 | President | Reveal Email/Phone |
4 | Senior Medical Advisor | Reveal Email/Phone |
AnBogen Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.4M | 22 | 22% | $19.8M | N/A |
What Is AnBogen Therapeutics?
Anbogen Therapeutics is a clinical stage precision oncology company dedicated in developing first/best-in-class personalized therapeutics and making difference in patients' life. We bridge the gap between discovery candidates and proof-of-concept indications to challenge the unmet needs.\n\nHeadquartered in Taiwan, we are advancing a pipeline of precision medicines for the treatment of solid tumors. Currently with three assets including ABT-101 and ABT-301 under clinical development.
keywords:N/A
$20M
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Taipei
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $3.4M | 22 | 5% | N/A |
#2 | $3.4M | 22 | -21% | N/A |
#3 | $2.2M | 24 | -8% | N/A |
#4 | $3.6M | 25 | 0% | N/A |
#5 | $3.7M | 25 | -14% | N/A |